|Genfit SA -- USA Stock|| |
USD 25.57 0.44 1.69%
Member of the Supervisory Board, Representative of Institut Pasteur de Lille
Prof. Francis Wallart has served as Member of the Supervisory Board Representative of Institut Pasteur de Lille at Genfit SA since September 15 1999. He also acts as Member of the Board of Cellial SA and IPL SED Atlantique Chairman of the Board of IPLInvest IPL SED Ile de France IPL SED Est IPL SED Bretagne IPLNord IPL Mediterranee and LCAM.
Executive Since 1999
33 3 20 16 40 00 http://www.genfit.com
The company has return on total asset (ROA)
of (21.4) %
which means that it has lost $21.4 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (41.34) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 10.12 M in total debt with debt to equity ratio (D/E) of 7.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Genfit SA has Current Ratio of 7.18 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases with a focus on the liver and gastroenterology worldwide. Genfit SA (GNFTF) is traded on OTC Market in USA. It is located in , Avenue Eug?ne Avin?eLoos, and employs 108 people.